Pentobarbital will reduce the extent or result of stiripentol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. If not able to prevent coadministration of stiripentol with strong CYP3A4 inducers, raise stiripentol dose. Psychological, tolerance and Actual physical dependence may well take place with continued use; clients with https://bonow740dfg9.wikiconverse.com/user